| Serial Number | 79413712 |
| Word Mark | RHYGAZE |
| Filing Date | Friday, November 8, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Tuesday, December 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical and medical preparations, namely, ophthalmologic preparations; biological medical and pharmaceutical preparations for treating ophthalmologic conditions, ailments, diseases and disorders; Pharmaceutical and medical preparations for treating eye diseases; biological medical and pharmaceutical preparations for treating eye diseases; pharmaceutical and biological preparations for use in cell cultures for medical purposes, namely, nucleic acids, protein arrays, protein conjugates, synthetic peptides, attenuated viruses, viral vectors and viral constructions; biological tissue cultures for medical use; biological tissue cultures intended for medical use in the diagnosis, prevention and treatment of diseases, in particular eye diseases; biological tissue cultures intended for medical use in gene therapy treatments; pharmaceutical preparations for use in genetic-based therapies, namely, gene therapy preparations, gene-editing preparations, genome-editing preparations, and preparations incorporating CRISPR-based therapeutic agents for the treatment of eye diseases and other medical conditions; biological preparations comprising genetically modified cells, modified nucleic acids, viral and non-viral vectors for use in gene therapy and genome-editing medical treatments; all of the foregoing excluding preparations or other goods for the treatment of cancer and oncological diseases and disorders |
| Goods and Services | Scientific and technological services, namely, research and design services relating to gene therapy, genetic-based therapies, genome-editing technologies, CRISPR technologies, molecular biology, biotechnology, pharmacy and medicine; quality control for others and authentication of data in the field of medical records using blockchain technology; design and development of computers and software; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine, in particular in the field of eye diseases; research and development services in the field of medical diagnostics, prophylaxis and therapy, in particular gene therapy; research services, namely, scientific examination and research of compounds and components intended for therapeutic or diagnostic use, in particular intended for use in relation to eye diseases; research services in the field of gene therapy; research and development in the fields of genome editing, CRISPR-based technologies, and genetic-engineering tools for medical and therapeutic use; scientific research for developing protocols, for technical planning, and for providing advice in the fields of molecular biology, biotechnology and pharmacy, in particular intended for use in the field of ocular diseases and gene therapies |
| Goods and Services | Medical services; medical services, namely medical diagnosis through molecular biology, genetic engineering and biotechnology methods, in particular in the field of eye diseases; therapy services, in particular gene therapy for medical treatment purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 2, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | RhyGaze AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | Basel CH-4031 CH |
| Event Date | Event Description |
| Thursday, January 2, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, January 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, April 9, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, April 16, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, April 17, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, June 20, 2025 | REFUSAL PROCESSED BY MPU |
| Friday, June 20, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 12, 2025 | REFUSAL PROCESSED BY IB |
| Friday, September 26, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |
| Monday, December 15, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 16, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |